BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9013833)

  • 41. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri.
    Brumm C; Rivière A; Wilckens C; Löning T
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(6):477-84. PubMed ID: 1980167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
    Bennett WP; el-Deiry WS; Rush WL; Guinee DG; Freedman AN; Caporaso NE; Welsh JA; Jones RT; Borkowski A; Travis WD; Fleming MV; Trastek V; Pairolero PC; Tazelaar HD; Midthun D; Jett JR; Liotta LA; Harris CC
    Clin Cancer Res; 1998 Jun; 4(6):1499-506. PubMed ID: 9626468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53.
    Mateo MS; Saez AI; Sanchez-Beato M; Garcia P; Sanchez-Verde L; Martinez JC; Orradre JL; Piris MA
    J Clin Pathol; 1997 Aug; 50(8):645-53. PubMed ID: 9301547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly.
    Santiago FS; Ishii H; Shafi S; Khurana R; Kanellakis P; Bhindi R; Ramirez MJ; Bobik A; Martin JF; Chesterman CN; Zachary IC; Khachigian LM
    Circ Res; 2007 Jul; 101(2):146-55. PubMed ID: 17556661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of p21WAF1/CIP1 in primary bladder tumors.
    Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
    Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DCC expression is related to mucinous differentiation but not changes in expression of p21(WAF1/Cip1) and p27Kip1, apoptosis, cell proliferation and human papillomavirus infection in uterine cervical adenocarcinomas.
    Saegusa M; Okayasu I
    Br J Cancer; 1999 Apr; 80(1-2):51-8. PubMed ID: 10389977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
    Saied IT; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.
    Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G
    J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic, and physiologic endometria.
    Huang SJ; Cheng L; Lewin KJ; Fu YS
    Pathol Res Pract; 1991 May; 187(4):487-95. PubMed ID: 1876529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
    el-Deiry WS; Tokino T; Waldman T; Oliner JD; Velculescu VE; Burrell M; Hill DE; Healy E; Rees JL; Hamilton SR
    Cancer Res; 1995 Jul; 55(13):2910-9. PubMed ID: 7796420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.
    Park YN; Chae KJ; Kwon KW; Oh BK; Lee KS; Lee WJ; Park C
    Hepatogastroenterology; 2003; 50(53):1292-6. PubMed ID: 14571721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of p21WAF1/CIP1 in bladder cancer: relation to schistosomiasis.
    Eissa S; Swelam M; Shaker Y; Abdel-Fattah M; Khalifa A
    IUBMB Life; 1999 Jul; 48(1):115-9. PubMed ID: 10791925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD56 is Expressed in Uterine Smooth Muscle Tumors.
    Karpathiou G; Chauleur C; Papoudou-Bai A; Dagher S; Peoc'h M
    Int J Gynecol Pathol; 2021 Jul; 40(4):315-323. PubMed ID: 32897962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy.
    Costa MJ; Hansen CL; Walls JE; Scudder SA
    Hum Pathol; 1999 Jun; 30(6):640-7. PubMed ID: 10374771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
    Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p21WAF1/CIP1 expression in primary lung adenocarcinomas: heterogeneous expression in tumor tissues and correlation with p53 expression and proliferative activities.
    Takeshima Y; Yamasaki M; Nishisaka T; Kitaguchi S; Inai K
    Carcinogenesis; 1998 Oct; 19(10):1755-61. PubMed ID: 9806155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. p21WAF1/CIP1 protein expression in primary ovarian cancer.
    Ferrandina G; Stoler A; Fagotti A; Fanfani F; Sacco R; De Pasqua A; Mancuso S; Scambia G
    Int J Oncol; 2000 Dec; 17(6):1231-5. PubMed ID: 11078810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.